Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor

Recent Results Cancer Res. 1994:135:171-84. doi: 10.1007/978-3-642-85039-4_17.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Neoplasm / pharmacology
  • Antibodies, Neoplasm / therapeutic use*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / therapy*
  • Cell Division / drug effects
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / biosynthesis*
  • ErbB Receptors / immunology
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Glioma / genetics
  • Glioma / metabolism
  • Glioma / therapy*
  • Humans
  • Immunotherapy*
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / immunology
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Protein-Tyrosine Kinases / metabolism
  • Suramin / pharmacology
  • Treatment Outcome
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Neoplasm Proteins
  • Suramin
  • Epidermal Growth Factor
  • ErbB Receptors
  • Protein-Tyrosine Kinases